Primmune Therapeutics

Primmune Therapeutics is a biotech company in San Diego, United States, founded in 2017. It has raised $61.7M across 3 rounds, most recently a $23.3M Series B in January 2026.

Home - Primmune

Employees
1–10
Founded
2017
Business Model
B2B
Total Funding
$61.7M
Last Round
$23.3M Series BJan 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Primmune is a clinical-stage biotechnology company developing systemic cancer immunotherapies that activate the immune system in a precise and controlled manner. The company is advancing therapies designed to strengthen antitumor immunity, enhance the impact of existing treatments, and improve long-term disease control. Its lead investigational program, PRTX007, is an orally administered, systemically active small-molecule agonist of toll-like receptor 7 (TLR7) designed to activate plasmacytoid dendritic cells that coordinate innate and adaptive immune responses critical to effective cancer immunotherapy.

Summary

It lists 1–10 employees. It has raised $61.7M in total across 3 rounds, most recently a $23.3M Series B round in Jan 2026. Investors include Bioqube Ventures, OrbiMed and Oberland Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJan 2026
$23.3M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Primmune Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/primmune-therapeutics"><img src="https://indexed.vc/api/badge/company/primmune-therapeutics" alt="Primmune Therapeutics on Indexed.vc" width="260" height="76" /></a>